Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04862689 · ClinicalTrials.gov registry record · NA

Investigation of the Ringer Perfusion Balloon Catheter (Ringer PTCA)

A NA study, sponsored by Vascular Solutions.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT04862689 is a NA study that has completed, run by Vascular Solutions. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04862689, a NA study, has completed, sponsored by Vascular Solutions.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The objective of this study is to demonstrate safe and effective use of the Ringer perfusion balloon catheter for dilatation/pre-dilatation of coronary stenoses during percutaneous coronary intervention (PCI).

Interventions

  • DEVICE Ringer Perfusion Balloon Catheter

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-05-01
Est. Completion 2023-06-30
Phase NA

Sponsor

Vascular Solutions

7 total trials

What the Registry Record Tells You About NCT04862689

The ClinicalTrials.gov registry entry for NCT04862689 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vascular Solutions, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Ringer Perfusion Balloon Catheter is the first listed.

NCT04862689 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04862689 about?

NCT04862689 is a clinical study titled "Investigation of the Ringer Perfusion Balloon Catheter (Ringer PTCA)". The objective of this study is to demonstrate safe and effective use of the Ringer perfusion balloon catheter for dilatation/pre-dilatation of coronary stenoses during percutaneous coronary intervention (PCI).

What is the current status of trial NCT04862689?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-05-01. Estimated completion is 2023-06-30.

What interventions are being tested in trial NCT04862689?

The interventions under investigation include: Ringer Perfusion Balloon Catheter (DEVICE).

Who is sponsoring clinical trial NCT04862689?

This trial is sponsored by Vascular Solutions, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.